New York City-based Weill Cornell Medicine received a $61.9 million grant from the National Institutes of Health's National Center for Advancing Translational Sciences Sept. 9 to continue funding its Clinical and Translational Science Center, it said in an email to Becker's.
The award, which is the largest federal grant ever funded to the system, will continue to fund the center until 2027. The center was founded in 2007 and has been led by Julianne Imperato-McGinley, MD, since its inception.
"We're excited to continue collaborating with our partner institutions to advance medical innovations to improve human health," Dr. Imperato-McGinley said. "The CTSC drives innovation by creating novel initiatives that are implemented as an interdisciplinary team. Gone are the days of the single researcher. Team science is how important advances are accomplished. One researcher may have an idea, and others enhance the idea [by] stimulating innovation. That's the CTSC's approach."